Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 28
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Autoimmun ; 135: 102977, 2023 02.
Artículo en Inglés | MEDLINE | ID: mdl-36621175

RESUMEN

Children and adolescents with early onset autoimmune diseases have a different seasonality of month of birth than the general population. This pattern is consistent with an infection during pregnancy affecting the fetus or an infection immediately after birth that act as early triggers of the autoimmune diseases. We present data supporting the use of Rotavirus vaccinations in the reduction of incidence of childhood T1D and propose further investigations into whether other anti-virus vaccinations may reduce the burden of other autoimmune diseases such as multiple sclerosis, atopic dermatitis, psoriasis and subtypes of rheumatoid arthritis, Hashimoto thyroiditis.


Asunto(s)
Artritis Reumatoide , Enfermedades Autoinmunes , Diabetes Mellitus Tipo 1 , Virosis , Niño , Adolescente , Humanos , Femenino , Embarazo , Mujeres Embarazadas , Artritis Reumatoide/complicaciones , Virosis/complicaciones , Virosis/epidemiología
2.
J Card Surg ; 37(4): 760-768, 2022 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-35112395

RESUMEN

BACKGROUND: End-stage renal disease (ESRD) has been shown to be associated with increased mortality in patients undergoing cardiac surgery. We aimed to compare the short- and mid-term mortality after cardiac surgery of patients with dialysis-dependent ESRD (DD-ESRD) to patients with normal renal function (NRF), using national registries: the ESRD registry, the adult cardiac surgery registry (ACSR), and the National Mortality Registry. METHODS: The study population comprised 8207 adult patients who underwent either isolated coronary artery bypass grafting (CABG), isolated aortic valve replacement (AVR), isolated mitral valve replacement (MVR), or CABG + valve-related procedure, between January 2017 and April 2019. Data were retrospectively extracted and reported to the ACSR by the department of medical records of each medical center. RESULTS: One hundred and four DD-ESRD patients (mean age 63.2 ± 8.8 years, 83.7% males) were compared with 8103 NRF patients (mean age 64.9 ± 9.8 years, 77.6% males). Median follow-up for the total cohort was of 32.0 months (IQR; 25.0, 40.0). In DD-ESRD compared to NRF patients, 30-day mortality was higher (14.4% vs. 2.3%, respectively, p = 0.0001) and 4-year survival was significantly lower (44% ± 0.06 vs. 91% ± 0.04, respectively, p = 0.0001). Fifty-three percent of DD-ESRD 30-day mortality was caused by sepsis. Risk factors associated with reduced midterm survival included: DD-ESRD patients (HR = 4.7, 95% CI; 1.2-18.2), MVR procedure (HR = 1.5, 95% CI; 1.04-2.1) and combined CABG + valve-related procedure (HR = 1.6, 95% CI; 1.2-2.04). CONCLUSIONS: Preoperative DD-ESRD was associated with a significant increase in 30-day and mid-term mortality after cardiac surgery. The highest mortality rate was observed in valvular and combined procedures.


Asunto(s)
Procedimientos Quirúrgicos Cardíacos , Implantación de Prótesis de Válvulas Cardíacas , Fallo Renal Crónico , Adulto , Anciano , Válvula Aórtica/cirugía , Femenino , Implantación de Prótesis de Válvulas Cardíacas/métodos , Humanos , Israel/epidemiología , Fallo Renal Crónico/complicaciones , Masculino , Persona de Mediana Edad , Sistema de Registros , Diálisis Renal , Estudios Retrospectivos , Factores de Riesgo , Resultado del Tratamiento
3.
Childs Nerv Syst ; 36(2): 411-416, 2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-31292758

RESUMEN

PURPOSE: Cerebral palsy is the most common physical disability in childhood. Our aim was to study the prevalence of wheelchair-dependent cerebral palsy (equivalent to gross motor function classification system level IV/V) among Jewish and Arab children in Israel and to investigate differences between the children of the two population groups. METHODS: Children diagnosed with cerebral palsy born in the years 2005-2006 were located through the Israel National Insurance Institute database. Demographic and clinical data were retrieved from children's records. RESULTS: Overall prevalence in Israel was 0.8 (0.7-0.9) per 1000 live births. The prevalence was significantly higher among Arabs (1.2:1000) than Jews (0.6:1000; OR = 1.6, 95% CI 1.2-2.1, p = 0.001) and was highest among Arabs in the South (Bedouins) (2.8:1000). Consanguinity among parents and low socioeconomic status were significantly more common among Arab children with wheelchair- dependent cerebral palsy compared with Jews. Higher rates of children with cerebral palsy following term pregnancy were found in Arabs. Extreme preterm births, very low birth weight, and emergent cesarean section were more common among Jews compared with Arabs. CONCLUSIONS: This study revealed population group differences of cerebral palsy with Gross Motor Function Classification System levels IV and V. Higher rates of cerebral palsy, especially following term pregnancy in the Arab population, may be attributed to consanguinity and genetic factors. There is a need to tailor services to underserved population based on etiology: preterm births and genetic causes for the Jewish and Arab populations, respectively.


Asunto(s)
Parálisis Cerebral , Comparación Transcultural , Parálisis Cerebral/epidemiología , Cesárea , Niño , Femenino , Humanos , Lactante , Recién Nacido , Israel/epidemiología , Masculino , Embarazo , Prevalencia
4.
Pediatr Endocrinol Rev ; 17(4): 284-286, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32780950

RESUMEN

Recent epidemiological surveys performed in Australia, USA and Israel demonstrate that Rotavirus vaccination correlates with an attenuated prevalence and/or incidence of early childhood diabetes (T1D). Other studies failed to confirm the above.


Asunto(s)
Diabetes Mellitus Tipo 1 , Infecciones por Rotavirus , Vacunas Virales/efectos adversos , Niño , Diabetes Mellitus Tipo 1/etiología , Gastroenteritis , Humanos , Incidencia , Israel , Vacunación
5.
Isr Med Assoc J ; 21(10): 671-675, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31599509

RESUMEN

BACKGROUND: Recently, Israel established the first national-level adult cardiac surgery database, which was linked to the Society of Thoracic Surgeons (STS). OBJECTIVES: To validate and compare the STS predicted risk of mortality (PROM) to logistic EuroSCORE I (LESI) and EuroSCORE II (ESII) in Israeli patients undergoing cardiac surgery. METHODS: We retrospectively studied 1279 consecutive patients who underwent cardiac surgeries with a calculable PROM. Data were prospectively entered into our database and used to calculate PROM, LESI, and ESII. Scores were normalized and correlated using linear regression and Pearson's test. To examine model calibration, we plotted the total observed versus expected mortality for each score and across five risk-score subgroups. Model discrimination was assessed by measuring the area under the receiver operating curves. RESULTS: The observed 30-day operative mortality was 1.95%. The median (IQ1; IQ3) PROM, LESI, and the ESII scores were 1.45% (0.69; 3.22), 4.54% (2.28; 9.27), and 1.88% (1.18; 3.54), respectively, with observed over expected ratios of 0.63 (95% confidence interval [95%CI] 0.42-0.93), 0.59 (95%CI 0.40-0.87), and 0.24 (95%CI 0.17-0.36), respectively, (STS vs. ESII P = 0.36, STS vs. LESI P = 0.0001). There was good correlation among all scores. All models overestimated mortality. Model discrimination was high and similar for all three scores. Model calibration of the STS, PROM, and ESII were more accurate than the LESI, particularly in higher risk subgroups. CONCLUSIONS: All scores overestimated mortality. In Israeli patients, the STS, PROM, and ESII risk-scores were more reliable metrics than LESI, particularly in higher risk patients.


Asunto(s)
Procedimientos Quirúrgicos Cardíacos , Gestión de Riesgos/métodos , Gestión de Riesgos/estadística & datos numéricos , Anciano , Bases de Datos Factuales , Femenino , Humanos , Israel , Masculino , Persona de Mediana Edad , Reproducibilidad de los Resultados , Estudios Retrospectivos , Medición de Riesgo/métodos , Medición de Riesgo/estadística & datos numéricos , Factores de Riesgo , Índice de Severidad de la Enfermedad , Sociedades Médicas , Cirugía Torácica
6.
Pediatr Diabetes ; 19(4): 693-698, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29193540

RESUMEN

BACKGROUND: The global rise in incidence of type 1 diabetes (T1D) is too rapid to be attributed to susceptible genetic background, pinpointing a significant role for environmental factors. Unlike the theory that the need for genetic susceptibility has lessened over time, we hypothesized that the rise in T1D incidence is faster in a genetically susceptible population. SUBJECTS AND METHODS: The study population comprised of 5080 patients aged 0 to 17 years who were reported to the National Israel Diabetes Registry between 1997 and 2014. The patients were divided into familial cases (first-degree relative has T1D), and sporadic cases. Demographic and clinical data were retrieved from the registry. The change in annual percent (from the entire cohort) was computed separately for the sporadic and familial cohorts. RESULTS: The familial (n = 546; 10.7%) and sporadic (n = 4534; 89.3%) cases were comparable for gender, ethnicity, and age at diagnosis. Consanguinity was more common in the familial vs sporadic group (10% vs 6.1%; P = .001). The average annual percent change increased by 1.9% in the familial cases and decreased by 0.2% in the sporadic cases (P = .04). CONCLUSIONS: The rapid rise in the proportion of familial cases of T1D suggests that environmental factors impose higher diabetogenic pressure in patients with a susceptible genetic background.


Asunto(s)
Diabetes Mellitus Tipo 1/epidemiología , Familia , Adolescente , Niño , Preescolar , Consanguinidad , Diabetes Mellitus Tipo 1/genética , Salud de la Familia/estadística & datos numéricos , Femenino , Predisposición Genética a la Enfermedad , Humanos , Incidencia , Lactante , Recién Nacido , Israel/epidemiología , Masculino , Sistema de Registros
8.
Clin Endocrinol (Oxf) ; 85(5): 813-818, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27292870

RESUMEN

CONTEXT: The inconclusive evidence regarding long-term safety of recombinant human growth hormone (rhGH) therapy underlines the need for long-term large-scale cohorts. OBJECTIVE: To assess long-term mortality and cancer incidence among patients treated with rhGH during childhood in Israel. DESIGN: A population-based cohort study. SETTING: Data were retrieved from a national register established in 1988. Mortality data from the national population register were available through 31 December 2014. Data on cancer incidence from the national cancer registry were available through 31 December 2012. PARTICIPANTS: All patients ≤19 years approved for rhGH treatment during 1988-2009 were included. Patients were assigned to three risk categories, according to the underlying condition leading to growth disorder. MAIN OUTCOME MEASURES: All-cause mortality and cancer incidence rates were calculated, based on person-years at risk. Standardized mortality ratios (SMRs) and standardized incidence ratios (SIRs) were calculated, using the Israeli general population as a reference. RESULTS: Included were 1687 patients assigned to the low-risk category and 440 patients assigned to the intermediate-risk category. In the low-risk category, all-cause mortality and cancer incidence were not significantly different than expected (SMR 0·81, 95% CI 0·22-2·08 and SIR 0·76, 95% CI 0·09-2·73). In the intermediate-risk category, all-cause mortality and cancer incidence were significantly higher than expected (SMR 4·05, 95% CI 1·62-8·34 and SIR 4·52, 95% CI 1·22-11·57). CONCLUSIONS: No increased risk of mortality or cancer incidence was found in low-risk patients treated with rhGH during childhood. Patients with prior risk factors were at higher risk of both mortality and cancer.


Asunto(s)
Hormona de Crecimiento Humana/efectos adversos , Neoplasias/inducido químicamente , Edad de Inicio , Preescolar , Estudios de Cohortes , Femenino , Hormona de Crecimiento Humana/uso terapéutico , Humanos , Incidencia , Israel , Masculino , Mortalidad , Neoplasias/epidemiología , Neoplasias/mortalidad , Proteínas Recombinantes , Sistema de Registros , Medición de Riesgo
9.
Cytokine ; 69(1): 94-101, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25022967

RESUMEN

OBJECTIVE: Several genes, including IL-6 encoding pro-inflammatory cytokines, are involved in development of osteoarthritis and osteoporosis. The association of radiographic hand osteoarthritis (RHOA) and osteoporosis related phenotypes (RHOP) with polymorphisms in IL-6 has been reported inconsistently. The aim of this study was to examine the association, between RHOA and RHOP and IL-6 polymorphisms in two independent samples. METHODS: Two samples: UK females, including 1440 individuals assessed for RHOA and 3470 assessed for RHOP; Chuvash pedigree including 1499 females and males were assessed for RHOP and RHOA. SNPs were genotyped in the IL-6 genomic region, and used in association analysis with RHOA and RHOP phenotypes. RESULTS: RHOP phenotypes showed similar heritability estimates in both samples, ranging from 34.5 ± 5.5% to 61.0 ± 2.4%. RHOA in Chuvash had substantially lower heritability estimates compared to twins (e.g. OSP scores: 11.8 ± 2.3% vs. 39.2 ± 4.1%) with much higher prevalence and considerably stronger correlation with age (r = 0.811 vs. r = 0.505). RHOA in Chuvash sample may be traumatic in nature, caused by heavy and prolonged manual work related to their private farming. There were a number of statistically significant association results with both types of phenotypes. The most consistent result was obtained for JSN in both samples with SNP from the same haploblock. Their combined probability of no association was only p = 0.000003. Additionally, there were SNPs common for both RHOA and RHOP. CONCLUSIONS: We have shown polymorphisms in IL_6 are significantly associated with RHOA and hand RHOP in two samples having different ethnicity and lifestyle. Age × environment × genes interaction appears as an important factor of RHOA manifestation and progression.


Asunto(s)
Mano/patología , Interleucina-6/genética , Osteoartritis/genética , Osteoporosis/genética , Adolescente , Adulto , Anciano , Progresión de la Enfermedad , Femenino , Predisposición Genética a la Enfermedad , Humanos , Inflamación/genética , Inflamación/inmunología , Interleucina-6/inmunología , Masculino , Persona de Mediana Edad , Osteoartritis/inmunología , Osteoporosis/inmunología , Polimorfismo de Nucleótido Simple , Gemelos/genética , Adulto Joven
10.
Pediatr Diabetes ; 15(6): 422-7, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24283719

RESUMEN

OBJECTIVE: To assess the trends in the incidence of type 1 diabetes between 1997 and 2010 among 0-17-yr-old Israeli Jews and Arabs compared with global trends. METHODS: Data on children with newly diagnosed type 1 diabetes reported by pediatric endocrinologists from 19 medical centers to the Israel Center for Disease Control, as part of the National Diabetes Register. RESULTS: During 1997-2010, 2857 Jews and 757 Arabs were diagnosed with type 1 diabetes. The average age-adjusted incidence among Jews was higher than Arabs [12.2 per 100 000, 95% confidence interval (CI) 10.5-14.2 and 8.9 per 100 000, 95% CI 7.5-10.7, p = 0.0001, respectively], however, the annual percent change was higher for Arabs compared with Jews (4.0 vs. 3.6%, p = 0.005, respectively). The mean age at diagnosis was similar for Jews and Arabs (9.6 ± 4.4 vs. 9.9 ± 4.4 yr, p = 0.08), and it remained stable during 1997-2010 in both ethnic groups (p = 0.6). In both Jews and Arabs the highest annual percent change was observed in younger children. It was 4.9% for children aged 5-9 yr and 10.7% for children aged 0-4 yr, respectively. There were no differences in the frequency of diabetic ketoacidosis (DKA) between Jews (39.9%) and Arabs (41.3%), (p = 0.5). CONCLUSION: Type 1 diabetes incidence of Jews and Arabs in Israel is increasing. The incidence is higher in Jews than in Arabs; however, the annual percent change is higher in Arabs than in Jews. In both Ethnic groups the incidence of type 1 diabetes is increasing especially among young children.


Asunto(s)
Árabes/estadística & datos numéricos , Diabetes Mellitus Tipo 1/epidemiología , Judíos/estadística & datos numéricos , Adolescente , Niño , Preescolar , Femenino , Humanos , Incidencia , Lactante , Recién Nacido , Israel/epidemiología , Masculino , Sistema de Registros
11.
Children (Basel) ; 11(2)2024 Jan 23.
Artículo en Inglés | MEDLINE | ID: mdl-38397254

RESUMEN

Background: The impact of the COVID-19 pandemic on the incidence rate of childhood type 1 diabetes (T1D) is controversial. Our aim was to analyze the incidence of new-onset T1D among children aged 0-17 before and during the COVID-19 pandemic in Israel. Methods: Data obtained from the national T1D registry for children aged 0-17 were analyzed for the pre-pandemic (1997-2019) and pandemic (2020-2022) periods. In the pre-pandemic period, 7246 children with newly diagnosed T1D were compared with 1490 children diagnosed during the pandemic period. Results: T1D incidence significantly increased in the 0-17 age group from a mean of 12.9/105 (pre-pandemic) to 17.7/105 and 16.7/105 during the first two years of the pandemic (2020 and 2021, respectively) (p = 0.0001). Stratifying by age group (0-4, 5-9, 10-14, and 15-17) revealed a significant increase in the 5-9, 10-14, and 15-17 groups, both in 2020 (p = 0.0001) and in 2021 (p = 0.0001). The incidence rate in the 0-4 age group showed no change in the first year of the pandemic (2020) (p = 0.4). However, in the second year of the pandemic (2021), there was a significant increase from 6.3/105 in the pre-pandemic period to 9.1/105 (p = 0.001). Anti-COVID-19 vaccination in 2022 led to a significant decrease in the incidence rates in the 10-14 and 15-17 age groups (p = 0.03 and p = 0.02, respectively). Conclusion: The COVID-19 pandemic was associated with a significant increase in the incidence of new-onset T1D in prepubertal and pubertal children. Anti-COVID-19 vaccination decreased the incidence rate significantly only in pubertal children.

12.
Infect Prev Pract ; 6(1): 100334, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38235125

RESUMEN

Background: We compared the effect of perioperative COVID-19, before and after vaccination, on 30-day mortality after cardiac surgery. Methods: Data was extracted from several national registries. The study period was March 1st, 2020-March 31st, 2022. Results: 2594 adult patients underwent cardiac surgery before the availability of a universal COVID-19 vaccine. 33 patients were diagnosed with COVID-19 prior to surgery (mean age 58.3±10.0, mean length of time 73.6±60.1 days) and 7 patients were diagnosed with COVID-19 0-14 days after surgery (age 66.4±7.6). These were compared to 4426 patients who underwent cardiac surgery after the availability of a universal vaccine: 469 patients were diagnosed with COVID-19 prior to surgery (age 62.1±10.1, length of time 175.8±158.2) and 32 patients diagnosed with COVID-19 0-14 days after surgery (age 60.8±14.5). In patients diagnosed with COVID-19 prior to surgery, there was no excess 30-day mortality either before or after vaccination (1 (3.0%) vs. 57 (2.2%), respectively, P<0.8, and 8 (1.7%) vs. 87 (2.2%), respectively, P<0.5). Patients diagnosed with COVID-19 after surgery, but before vaccination, had significantly higher 30-day mortality compared to COVID-19 negative patients (2 (28.6%) vs. 56 (2.2%) respectively, P<0.0001). This excess mortality disappeared after universal vaccination (1 (3.1%) vs. 94 (2.1%) respectively, P<0.7). Conclusions: COVID-19, when diagnosed in the early post-operative period, was a risk factor for mortality before available vaccinations, but not after vaccination was widely available. Pre-surgery screening and post-surgical isolation is essential until vaccines are available. This data may be useful for patient management in future respiratory pandemics.

13.
Pediatr Diabetes ; 13(4): 326-33, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22151880

RESUMEN

BACKGROUND: Type 1 diabetes is an autoimmune disease occurring in genetically susceptible individuals. The precipitating cause is unclear. Recently, the Second Lebanon War exposed a large civilian population in northern Israel to significant psychological stress in the form of repeated barrages of missile attacks. HYPOTHESIS: We hypothesized that trends in regional incidence of type 1 diabetes before and after the war would reflect an association with stress. METHODS: All type 1 diabetes patients aged 0-17 yr who were reported to the Israel Juvenile Diabetes Register (n = 1822) in the four pre-war (2002-2005) and two post-war years (2006-2007) were included in the study. The patients were stratified by gender, age, ethnicity, family history of type 1 diabetes, season at diagnosis, and region of residency, namely, those who lived in the northern regions that were attacked and those in other regions. RESULTS: The post-war incidence of type 1 diabetes was increased in the northern regions (rate ratio, RR = 1.27; p = 0.037), with no change in the other regions. This change was more prominent in males (RR = 1.55; p = 0.005) but similar in summer and winter, in different ages, and in different ethnic groups. There was no change in the proportion of new patients with a family history of the disease. CONCLUSIONS: For the first time in a large population, we found a positive association between the trauma of war and an increase in the incidence of type 1 diabetes in children and adolescents. The increase in incidence was not associated with genetic susceptibility to the disease.


Asunto(s)
Diabetes Mellitus Tipo 1/epidemiología , Estrés Psicológico/complicaciones , Adolescente , Niño , Preescolar , Diabetes Mellitus Tipo 1/etiología , Femenino , Humanos , Incidencia , Lactante , Israel/epidemiología , Masculino , Estaciones del Año , Trastornos por Estrés Postraumático , Estrés Psicológico/epidemiología , Guerra
14.
Ann Hum Biol ; 39(3): 214-22, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22621755

RESUMEN

BACKGROUND: Occurrence and progression of age-related irreversible degradations of skeletal joints, osteoarthritis (OA), has a stochastic nature. However, it is commonly described using polynomial models, which may not necessarily be optimal. AIM: To implement a stochastic model of gradual accumulation of the distinct changes for estimating individuals' putative age at onset and risk of the process advancing in the OA longitudinal data. SUBJECTS AND METHODS: The model was formulated as a discrete Markov process. It was applied to radiographic knee osteoarthritis (RKOA) data: 243 Kellgren-Lawrence (K/L) and 207 osteophytes (OP) score histories from the 15-year follow-up Chingford study. RESULTS: The model performance was examined in Monte-Carlo simulations. The mean age at onset of knee osteoarthritis was: 53.04 and 53.23 years and the average annual risk of one K/L and one OP grade appearance was: 0.066 and 0.025, respectively. The analysis also suggested that there is 3-4 years difference between the inferred age at onset and the age when knee osteoarthritis becomes detectable on radiograph. CONCLUSION: The stochastic model provides more accurate description of the empiric data compared with the corresponding polynomial model. The model-based individual's estimates could be used as an important tool to fit age-related patterns of the corresponding diseases and conditions.


Asunto(s)
Envejecimiento/patología , Modelos Biológicos , Osteoartritis de la Rodilla/epidemiología , Estadística como Asunto , Anciano , Anciano de 80 o más Años , Simulación por Computador , Progresión de la Enfermedad , Femenino , Humanos , Articulaciones/patología , Londres/epidemiología , Estudios Longitudinales , Persona de Mediana Edad , Método de Montecarlo , Osteoartritis de la Rodilla/diagnóstico por imagen , Osteoartritis de la Rodilla/patología , Radiografía , Procesos Estocásticos
15.
J Cardiothorac Surg ; 17(1): 68, 2022 Apr 05.
Artículo en Inglés | MEDLINE | ID: mdl-35382843

RESUMEN

BACKGROUND: Long-term survival is an important metric in assessing procedural value. We previously confirmed that the Society of Thoracic Surgeons predicted risk of mortality score (PROM) accurately predicts 30-day mortality in Israeli patients. The present study investigated the ability of the PROM to reliably predict long-term survival. METHODS: Data on 1279 patients undergoing cardiac surgery were prospectively entered into our database and used to calculate PROM. Long-term mortality was obtained from the Israeli Social Security Database. Patients were stratified into five cohorts according to PROM (A: 0-0.99%, B: 1.0-1.99%, C: 2.0-2.99%, D: 3.0-4.99% and E: ≥ 5.0%). Kaplan-Meier estimates of survival were calculated for each cohort and compared by Wilcoxon signed-rank test. We used C-statistics to assess model discrimination. Cox regression analysis was performed to identify predictors of long-term survival. RESULTS: Follow-up was achieved for 1256 (98%) patients over a mean period of 62 ± 28 months (median 64, range 0-107). Mean survival of the entire cohort was 95 ± 1 (95% CI 93-96) months. Higher PROM was associated with reduced survival: A-104 ± 1 (103-105) months, B-96 ± 2 (93-99) months, C-93 ± 3 (88-98) months, D-89 ± 3 (84-94) months, E-74 ± 3 (68-80) months (p < 0.0001). The Area Under the Curve was 0.76 ± 0.02 indicating excellent model discrimination. Independent predictors of long-term mortality included advanced age, lower ejection fraction, reoperation, diabetes mellitus, dialysis and PROM. CONCLUSIONS: The PROM was a reliable predictor of long-term survival in Israeli patients undergoing cardiac surgery. The PROM might be a useful metric for assessing procedural value and surgical decision-making.


Asunto(s)
Procedimientos Quirúrgicos Cardíacos , Cirujanos , Cirugía Torácica , Humanos , Israel/epidemiología , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Resultado del Tratamiento
16.
Pediatr Infect Dis J ; 40(8): 771-773, 2021 08 01.
Artículo en Inglés | MEDLINE | ID: mdl-34250976

RESUMEN

BACKGROUND: Recent studies showed that rotavirus vaccination may affect the prevalence of type 1 diabetes (T1D). The aim of the study was to determine the prevalence of early childhood (<5 years) T1D before and during the introduction of rotavirus vaccination in Israel by syndromic surveillance. METHODS: Data on insulin purchases reported by Israel's four Health Maintenance Organizations (HMOs) were retrieved from the National Program for Quality Indicators in Community Healthcare. RESULTS: During the prevaccination years (2002-2007), a steady increase in insulin purchases was reported in the young (<5 years). The period percent change (PC) of children <5 years old diagnosed with T1D inferred from purchased insulin prescriptions increased by 50.0%, and the annual percent change (APC) increased by 10.0% (p = 0.01). During the period of free, universal Rotavirus vaccination (2011-2018), the PC for T1D diagnoses among children <5 years of age decreased by 3.8% with an APC of -2.5% (p = 0.14). There was a significant difference (p = 0.002) between the increasing trend in insulin use before vaccination versus the decreasing trend after vaccination. CONCLUSION: Rotavirus vaccination correlated with attenuation of the increasing rate in the prevalence of T1D in <5-year-old children in Israel.


Asunto(s)
Comportamiento del Consumidor/estadística & datos numéricos , Diabetes Mellitus Tipo 1/epidemiología , Insulina/economía , Infecciones por Rotavirus/prevención & control , Vacunación/estadística & datos numéricos , Preescolar , Recolección de Datos/métodos , Humanos , Lactante , Israel/epidemiología , Prevalencia , Vigilancia de Guardia
17.
Surg Obes Relat Dis ; 16(1): 80-89, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31735570

RESUMEN

BACKGROUND: Obesity rates in Israel are increasing, and so is the popularity of bariatric surgeries, which reached in 2017 a prevalence rate of 1428.7 surgeries per million citizens. However, data regarding patient characteristics and surgery outcomes, including complications, are limited and the procedure requires monitoring. OBJECTIVES: To establish a national bariatric surgery registry with high reliability and validity. SETTING: All private and public medical centers performing bariatric surgeries in the state of Israel. METHODS: The Israeli Bariatric Surgery Registry (IBSR) was established in June 2013 by the Israel Center for Disease Control in the Ministry of Health, in collaboration with the Israel Bariatric Surgery Society. An official directive of the Director General of the Ministry of Health as of 2013 made reporting of all bariatric surgeries carried out in Israel mandatory. The bariatric surgery centers relay clinical and surgical information to the IBSR. Presurgery and follow-up outcome information was retrieved from all 4 health maintenance organizations. RESULTS: All 32 certified bariatric units report to the national IBSR. National reporting rates increased from 46.3% in 2013 to 98.7% in 2017. Adherence to bariatric surgery guidelines also increased from 72.8% in 2013 to 98.7% in 2017, and fewer patients not fulfilling the guidelines underwent bariatric surgeries in 2017. Importantly, the considerable annual preregistry increase in surgical procedures has been halted. Registry data regarding obesity-related co-morbidities were validated against hospital files with high Cohen's kappa coefficients for hypertension (r = .8), diabetes (r = .8), and sleep apnea (r = .7). CONCLUSIONS: The national IBSR is an identified, validated, mandatory database with access to other national databases, which enables quality assurance of bariatric surgeries in Israel and short- and long-term postoperative follow-up.


Asunto(s)
Cirugía Bariátrica , Obesidad Mórbida/cirugía , Sistema de Registros , Adulto , Cirugía Bariátrica/efectos adversos , Cirugía Bariátrica/estadística & datos numéricos , Cirugía Bariátrica/tendencias , Comorbilidad , Femenino , Humanos , Israel , Masculino , Persona de Mediana Edad
18.
Obes Surg ; 30(1): 296-303, 2020 01.
Artículo en Inglés | MEDLINE | ID: mdl-31478132

RESUMEN

OBJECTIVE: Most published work on bariatric surgery (BS) in adolescents describes outcomes after laparoscopic adjustable gastric banding (LAGB) or Roux-en-Y gastric bypass. We compared the efficacy of LAGB and laparoscopic sleeve gastrectomy (LSG) in adolescents. METHODS: A National Bariatric Registry was queried for adolescents who underwent BS between June 2013 and December 2015. We collected data on weight and height at baseline and 1-year following surgery, subsequent hospitalizations, interventions, and mortality, which were compared at 30 days post-surgery and until last follow-up (maximum 4.2 years post-surgery). Mortality and hospitalization data were extracted from national databases. RESULTS: Two hundred fifty-nine adolescents (60% females) aged 12-19 years were included. Mean age and body mass index (BMI) were 17.5 ± 1.2 years and 45.1 ± 5.0 kg/m2, respectively. LSG (n = 227, 87.6%) and LAGB (n = 32, 12.4%) were the most common procedures performed. LSG group achieved greater average at 1 year BMI loss compared to LAGB group (15.4 ± 4.7 kg/m2 vs. 10.3 ± 5.1 kg/m2 respectively; p = 0.0001) and higher rate with BMI < 30 kg/m2 1 year post-surgery (57.7% (n = 131) vs. 25% (n = 8), respectively; p = 0.0005). Males who underwent LSG reduced BMI more than their female counterparts (p = 0.0001), LSG was the strongest independent predictor for BMI < 30 after 1 year (OR = 4.1; 95% CI 1.7-9.9) followed by age (OR = 1.3; 95% CI1.0-1.6). No mortality was observed. Postoperative hospitalizations between the two groups did not differ (hazard ratio 2.4; 95% CI 0.7-7.9; p = 0.1). CONCLUSION: Compared to LAGB, LSG is superior regarding weight loss with a similar risk of short- and long-term hospitalizations, complications, and interventional procedures. Males lose more weight following LSG.


Asunto(s)
Gastrectomía , Gastroplastia , Laparoscopía/métodos , Obesidad Mórbida/cirugía , Obesidad Infantil/cirugía , Adolescente , Índice de Masa Corporal , Niño , Bases de Datos Factuales , Femenino , Gastrectomía/efectos adversos , Gastrectomía/métodos , Gastrectomía/estadística & datos numéricos , Gastroplastia/efectos adversos , Gastroplastia/métodos , Gastroplastia/estadística & datos numéricos , Humanos , Israel/epidemiología , Laparoscopía/efectos adversos , Laparoscopía/estadística & datos numéricos , Tiempo de Internación , Masculino , Obesidad Mórbida/epidemiología , Obesidad Infantil/epidemiología , Sistema de Registros , Estudios Retrospectivos , Resultado del Tratamiento , Pérdida de Peso/fisiología , Adulto Joven
19.
Obes Rev ; 20(11): 1507-1522, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31419378

RESUMEN

The objective of the study is to provide evidence-based guidance on nutritional management and optimal care for pregnancy after bariatric surgery. A consensus meeting of international and multidisciplinary experts was held to identify relevant research questions in relation to pregnancy after bariatric surgery. A systematic search of available literature was performed, and the ADAPTE protocol for guideline development followed. All available evidence was graded and further discussed during group meetings to formulate recommendations. Where evidence of sufficient quality was lacking, the group made consensus recommendations based on expert clinical experience. The main outcome measures are timing of pregnancy, contraceptive choice, nutritional advice and supplementation, clinical follow-up of pregnancy, and breastfeeding. We provide recommendations for periconception, antenatal, and postnatal care for women following surgery. These recommendations are summarized in a table and print-friendly format. Women of reproductive age with a history of bariatric surgery should receive specialized care regarding their reproductive health. Many recommendations are not supported by high-quality evidence and warrant further research. These areas are highlighted in the paper.


Asunto(s)
Cirugía Bariátrica , Obesidad Mórbida/cirugía , Atención Preconceptiva , Complicaciones del Embarazo/fisiopatología , Consenso , Femenino , Guías como Asunto , Humanos , Obesidad Mórbida/fisiopatología , Atención Posnatal , Embarazo , Complicaciones del Embarazo/etiología , Resultado del Embarazo
20.
Surg Obes Relat Dis ; 14(2): 175-180, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-29217131

RESUMEN

BACKGROUND: The impact of omega-loop gastric bypass (OLGB) on weight loss and liver enzymes remains inconclusive. OBJECTIVE: The aim of this study was to compare the impact of sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), and OLGB on weight loss and liver enzyme levels. SETTING: National Bariatric Surgery Registry. METHODS: The study included 10,675 cases of SG, 1590 cases of RYGB, and 469 cases of OLGB that had available baseline and 1-year (12 ± 2 mo) follow-up data. RESULTS: The highest percentage of excess weight loss was achieved by the OLGB group (84.5% ± 26.7%), followed by the SG (78.5% ± 26.0%) and RYGB (72.0% ± 26.5%) groups (P<.05). The data show that 10% of OLGB cases, 5.2% of RYGB cases, and 1.9% of SG cases (P<.001) had increases in alanine aminotransferase levels, from a normal baseline mean of 23.9 ± 7.5 U/L to an abnormal mean of 64.8.7 ± 66.0 U/L, at follow-up. Similar trends were observed for aspartate aminotransferase and alkaline phosphatase. A regression analysis showed that OLGB was a predictive risk factor for normal baseline alanine aminotransferase levels becoming abnormal postoperatively compared with SG (odds ratio [OR] = 5.65) or RYGB (OR = 2.08) (P<.001). Similarly, OLGB was a predictive risk factor for baseline aspartate aminotransferase and alkaline phosphatase levels becoming abnormal postoperatively. Female sex was the only other meaningful predictive risk of alanine aminotransferase (OR = 2.45) and aspartate aminotransferase (OR = 1.82) becoming abnormal postoperatively. CONCLUSION: This study confirmed the strengths of OLGB weight loss outcomes but also demonstrated its negative impact on liver enzymes. Thus, patients and caregivers should be informed of the risks, and close follow-up is warranted.


Asunto(s)
Alanina Transaminasa/sangre , Fosfatasa Alcalina/sangre , Gastrectomía/métodos , Derivación Gástrica/métodos , Obesidad Mórbida/cirugía , Sistema de Registros , Adulto , Análisis de Varianza , Índice de Masa Corporal , Femenino , Estudios de Seguimiento , Gastrectomía/efectos adversos , Derivación Gástrica/efectos adversos , Humanos , Israel , Laparoscopía/efectos adversos , Laparoscopía/métodos , Pruebas de Función Hepática , Masculino , Persona de Mediana Edad , Obesidad Mórbida/diagnóstico , Complicaciones Posoperatorias/sangre , Complicaciones Posoperatorias/enzimología , Valor Predictivo de las Pruebas , Medición de Riesgo , Factores de Tiempo , Resultado del Tratamiento , Pérdida de Peso/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA